tiprankstipranks
The Fly

Collegium Pharmaceutical sees FY25 revenue $735M-$750M, consensus $739.84M

Collegium Pharmaceutical sees FY25 revenue $735M-$750M, consensus $739.84M

Sees FY25: Adjusted EBITDA is expected in the range of $435 million to $450 million. Adjusted operating expenses are expected in the range of $220 million to $230 million.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

1